Recent Insider Transactions • May 17
Independent Director recently bought CA$347k worth of stock On the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months. Price Target Changed • May 11
Price target increased by 10% to CA$35.44 Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year. Reported Earnings • May 11
First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025) First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year. Actualités en direct • May 10
Extendicare Expands Home Health Care With Major Acquisitions and Raises Dividend Extendicare reported strong Q1 2026 results, with home health care cited as a key driver of performance.
The company expanded its home health footprint through acquisitions of CBI Home Health, Closing the Gap and nine Class C long-term care homes.
Extendicare issued $450 million of senior unsecured notes, restructured its credit facilities and announced a 5.0% increase in its monthly dividend.
For you as an investor, the update highlights a clear push into home health services, supported by sizable acquisitions, including the $570 million purchase of CBI Home Health in April. The addition of Closing the Gap and nine Class C long-term care homes points to a larger and more diversified care platform, with a mix of in-home and facility-based services.
On the balance sheet side, the $450 million senior unsecured notes and credit facility changes suggest the company is aligning its financing with this expanded scale. The 5.0% dividend increase, alongside a pre-tax gain realized from the sale of a vacated Class C property, reflects management’s current approach to capital returns while still funding growth. Investors may want to watch how integration of the new assets progresses, as well as how the updated capital structure affects interest costs and financial flexibility over time. Annonce • May 09
Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026 The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Buy Or Sell Opportunity • Apr 24
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 33% to CA$29.61. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Declared Dividend • Apr 20
Dividend of CA$0.044 announced Shareholders will receive a dividend of CA$0.044. Ex-date: 30th April 2026 Payment date: 15th May 2026 Dividend yield will be 1.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Buy Or Sell Opportunity • Apr 09
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 35% to CA$29.52. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Annonce • Apr 06
Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026 Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026 Recent Insider Transactions Derivative • Mar 20
CEO, President & Director exercised options to buy CA$1.9m worth of stock. On the 17th of March, Michael Guerriere exercised options to buy 75k shares at a strike price of around CA$26.47, costing a total of CA$2.0m. This transaction amounted to 22% of their direct individual holding at the time of the trade. Since June 2025, Michael has owned 337.97k shares directly. Company insiders have collectively bought CA$6.9m more than they sold, via options and on-market transactions, in the last 12 months. Declared Dividend • Mar 19
Dividend of CA$0.044 announced Shareholders will receive a dividend of CA$0.044. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 1.9%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Mar 19
Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-Election Extendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate. Price Target Changed • Mar 01
Price target increased by 15% to CA$29.08 Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year. Reported Earnings • Feb 27
Full year 2025 earnings released: EPS: CA$1.13 (vs CA$0.89 in FY 2024) Full year 2025 results: EPS: CA$1.13 (up from CA$0.89 in FY 2024). Revenue: CA$1.66b (up 13% from FY 2024). Net income: CA$96.7m (up 28% from FY 2024). Profit margin: 5.8% (up from 5.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth. Annonce • Feb 27
Extendicare Inc. Increases Cash Dividend for the Month of March 2026 Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases. Declared Dividend • Feb 19
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 27th February 2026 Payment date: 16th March 2026 Dividend yield will be 2.0%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Feb 17
Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Jan 27
Extendicare Inc., Annual General Meeting, Apr 16, 2026 Extendicare Inc., Annual General Meeting, Apr 16, 2026. Declared Dividend • Jan 18
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 30th January 2026 Payment date: 16th February 2026 Dividend yield will be 2.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jan 16
Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026 Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026 Annonce • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Declared Dividend • Dec 18
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Dec 13
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Recent Insider Transactions • Dec 07
Senior VP of ParaMed & CTO recently bought CA$213k worth of stock On the 4th of December, Steve Paraskevopoulos bought around 10k shares on-market at roughly CA$22.40 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$259k more in shares than they have sold in the last 12 months. Price Target Changed • Nov 26
Price target increased by 16% to CA$22.25 Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year. Annonce • Nov 20
Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million. Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million.
For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million.
The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share.
CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health. Declared Dividend • Nov 19
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 28th November 2025 Payment date: 15th December 2025 Dividend yield will be 2.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Nov 18
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CA$19.76, the stock trades at a trailing P/E ratio of 18.2x. Average forward P/E is 43x in the Healthcare industry in Canada. Total returns to shareholders of 253% over the past three years. Reported Earnings • Nov 14
Third quarter 2025 earnings released: EPS: CA$0.28 (vs CA$0.19 in 3Q 2024) Third quarter 2025 results: EPS: CA$0.28 (up from CA$0.19 in 3Q 2024). Revenue: CA$440.3m (up 23% from 3Q 2024). Net income: CA$24.1m (up 48% from 3Q 2024). Profit margin: 5.5% (up from 4.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 14
Price target increased by 14% to CA$18.75 Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year. Annonce • Nov 13
Extendicare Inc. announces Monthly dividend, payable on December 15, 2025 Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025. Annonce • Oct 15
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Oct 07
Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025 Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025 Declared Dividend • Sep 17
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Sep 15
Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025. Declared Dividend • Aug 17
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 29th August 2025 Payment date: 15th September 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 08
Second quarter 2025 earnings released: EPS: CA$0.38 (vs CA$0.31 in 2Q 2024) Second quarter 2025 results: EPS: CA$0.38 (up from CA$0.31 in 2Q 2024). Revenue: CA$383.4m (up 10.0% from 2Q 2024). Net income: CA$31.9m (up 23% from 2Q 2024). Profit margin: 8.3% (up from 7.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Annonce • Aug 07
Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025 The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. Declared Dividend • Jul 18
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 31st July 2025 Payment date: 15th August 2025 Dividend yield will be 3.8%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jul 15
Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Jul 07
Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025 Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025 Declared Dividend • Jun 19
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jun 18
Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Jun 03
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction.
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025. Declared Dividend • May 16
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 30th May 2025 Payment date: 16th June 2025 Dividend yield will be 3.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Recent Insider Transactions • May 11
Independent Director recently bought CA$199k worth of stock On the 8th of May, Donald Clow bought around 14k shares on-market at roughly CA$14.19 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$143k more in shares than they have sold in the last 12 months. Reported Earnings • May 07
First quarter 2025 earnings released First quarter 2025 results: Revenue: CA$374.7m (up 2.1% from 1Q 2024). Net income: CA$15.0m (up 15% from 1Q 2024). Profit margin: 4.0% (up from 3.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Annonce • May 07
Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025 The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. Declared Dividend • Apr 17
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 30th April 2025 Payment date: 15th May 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Apr 16
Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Annonce • Apr 03
Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025 Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025 Declared Dividend • Mar 20
Dividend of CA$0.042 announced Shareholders will receive a dividend of CA$0.042. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Recent Insider Transactions Derivative • Mar 19
CEO, President & Director exercised options to buy CA$1.0m worth of stock. On the 18th of March, Michael Guerriere exercised options to buy 79k shares at a strike price of around CA$13.03, costing a total of CA$1.0m. This transaction amounted to 31% of their direct individual holding at the time of the trade. Since March 2024, Michael has owned 258.82k shares directly. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months. Annonce • Mar 18
Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Mar 17
Extendicare Inc., Annual General Meeting, May 27, 2025 Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada Reported Earnings • Feb 28
Full year 2024 earnings released: EPS: CA$0.89 (vs CA$0.40 in FY 2023) Full year 2024 results: EPS: CA$0.89 (up from CA$0.40 in FY 2023). Revenue: CA$1.47b (up 12% from FY 2023). Net income: CA$75.2m (up 121% from FY 2023). Profit margin: 5.1% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Declared Dividend • Feb 20
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2025 Payment date: 17th March 2025 Dividend yield will be 4.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Feb 14
Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Price Target Changed • Feb 05
Price target increased by 8.6% to CA$11.40 Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year. Declared Dividend • Jan 17
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st January 2025 Payment date: 14th February 2025 Dividend yield will be 4.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025. Annonce • Jan 13
Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025 Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025 Declared Dividend • Dec 17
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Dec 13
Extendicare Announces December 2024 Dividend, Payable on January 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Declared Dividend • Nov 17
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 29th November 2024 Payment date: 16th December 2024 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 14
Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023) Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Annonce • Nov 13
Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024 The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. Declared Dividend • Oct 18
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Oct 15
Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Annonce • Oct 04
Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024 Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024 Declared Dividend • Sep 19
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Sep 16
Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Declared Dividend • Aug 15
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 5.8%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (69% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Price Target Changed • Aug 14
Price target increased by 10% to CA$9.17 Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year. Reported Earnings • Aug 13
Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023) Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Declared Dividend • Jul 17
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.5%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.